Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Norwegian Multiple Sclerosis Registry and Biobank.
Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Jacksonian seizure as the relapse symptom of multiple sclerosis.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.
Association between neuromyelitis optica and tuberculosis in a Chinese population.
Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs.
The squares test as a measure of hand function in multiple sclerosis.
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis.
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
[Current Status of Genetic Diagnosis of Charcot-Marie-Tooth Disease: Variety of the Disease-causing Genes].
Retinal Cell Degeneration in Animal Models.
Stem cells in neurology - current perspectives.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England : Results of a Modified Prescription-Event Monitoring Study.
Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Pages